Search

everythinglearnresearchcommunity

for

Search:↓

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Latanoprost may be a promising new treatment for hair loss.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

New compounds may help treat prostate cancer by reducing cell growth.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.